Shopping Cart
Professional article · Regenerative medicine
PRP Therapy: Therapeutic Properties, Mechanisms and Limitations
PRP therapy uses platelet-rich plasma prepared from the patient’s own blood. This article explains the biological properties under investigation, the importance of preparation and why clinical benefit must be assessed for each indication and protocol.
Autologous procedurePRP is prepared from the blood of the person being treated.
Not a standard productPlatelet, leukocyte and erythrocyte levels vary between systems.
Indication-specificFindings from one condition cannot simply be transferred to another tissue.
What is platelet-rich plasma?
PRP stands for platelet-rich plasma. Venous blood is collected and centrifuged so that its components separate in a controlled manner. The selected plasma fraction is intended to contain a higher platelet concentration than the original whole blood.
Platelets are best known for their role in haemostasis. They also contain signalling proteins involved in inflammation, cell communication, angiogenesis and tissue repair. This explains the therapeutic interest in PRP. Biological plausibility, however, does not prove that every clinical application is effective.
Important: PRP is not one identical medicine. The term covers autologous blood products with substantially different cellular and biochemical compositions.
Which therapeutic properties are being investigated?
After activation, platelets can release growth factors and signalling molecules such as PDGF, VEGF and TGF-β. These mediators act within a complex local environment of cells, proteins and inflammatory signals.
01
Inflammatory modulation
PRP may influence local pro- and anti-inflammatory pathways. It should not be described as generally anti-inflammatory because composition, tissue and timing all matter.
02
Cell communication
In laboratory models, signalling factors may influence the migration and activity of fibroblasts, endothelial cells and tissue-specific cells. PRP does not supply new stem cells.
03
Matrix remodelling
Effects on collagen, extracellular matrix and repair processes are being studied. Clinical relevance depends on the indication and tissue condition.
04
Vascular signalling
Some PRP components participate in angiogenic pathways. This does not mean that every treatment automatically or permanently improves blood flow.
Preparation: composition matters
The final product is defined by more than the platelet count. Relevant factors include collected blood volume, final plasma volume, absolute platelet dose, leukocyte and erythrocyte content, anticoagulant, activation and centrifugation conditions.
Leukocyte-poor and leukocyte-rich PRP may provoke different biological responses. Activated and non-activated PRP and fibrin-rich products should not be treated as equivalent.
Platelet concentrationonly one part of the biological dose
Final volumehelps determine the total delivered cell number
Cell profileleukocytes and erythrocytes change the product
Processrotor, RCF, time, braking and handling must work together
In musculoskeletal applications, some evidence suggests that delivered platelet dose may influence outcomes. This does not support a simple “more is better” rule.[5]
Where is PRP used or investigated?
PRP is used or studied in several medical specialties. The strength of evidence differs considerably between indications.
Orthopaedics and sports medicine
For knee osteoarthritis, some studies report temporary improvements in pain and function. Guidelines remain cautious or rate the evidence as limited. Symptom relief is not proof of reliable cartilage regeneration.[1][2]
Results in tendinopathy vary by tendon, duration, comparator and protocol. NICE continues to regard the evidence of efficacy as inadequate.[3]
Androgenetic hair loss
Controlled studies report possible improvements in hair density in selected patients. Preparation, intervals and outcome measurements vary widely. PRP does not replace dermatological investigation of the cause.
Chronic wounds
Adjunctive effects on wound closure and healing time are being studied. PRP does not replace offloading, infection control, vascular assessment, debridement or metabolic management.
Dermatology and aesthetic medicine
Research includes acne scars, skin quality and combinations with microneedling or energy-based procedures. Broad claims such as “removes wrinkles”, “clears acne” or “stops ageing” are not supported by the heterogeneous evidence.
Dentistry and surgery
Platelet concentrates are investigated as adjuncts in soft-tissue healing, bone augmentation and surgical procedures. PRP and PRF have different matrix structures and should not be treated as identical products.
Advantages of the autologous approach — and its limits
Because PRP is prepared from the patient’s own blood, the risk of classic immune rejection is generally lower than with foreign cell products. “Autologous” does not mean “risk-free”.
Temporary pain, tenderness, swelling, redness or bruising may occur. Depending on the treatment site, general risks include bleeding, infection and injury to adjacent structures. Published reports describe rarer adverse events as well.[4]
Particular medical assessment may be required in cases of:
- acute local or systemic infection,
- relevant platelet or blood-count abnormalities,
- coagulation disorders or anticoagulant medication,
- active or recently treated malignancy,
- known reactions to additives used in the process,
- complex haematological, immunological or systemic disease.
A general online checklist cannot replace individual history, diagnostics and a benefit-risk assessment.
Why do studies reach different conclusions?
Two trials may both use the label “PRP” while administering biologically different products. Differences in patient selection, disease stage, cell composition, dose, injection site, imaging guidance, co-treatment and follow-up make direct comparisons difficult.
Productplatelets, leukocytes, erythrocytes, plasma and activation
Protocolblood volume, RCF, rotor, runtime, braking and processing
Patientdiagnosis, severity, prior treatment and comorbidities
Endpointpain, function, imaging, healing rate or subjective rating
Systematic reviews therefore repeatedly identify heterogeneity and incomplete standardisation.[6] A positive result with one preparation cannot automatically be transferred to another PRP system or indication.
Is PRP a regenerative therapy?
PRP is often grouped under regenerative medicine, but the term should be used precisely. It may influence processes associated with repair, inflammatory regulation and matrix remodelling. It does not necessarily create completely new, functionally equivalent tissue.
Reduced pain or improved function is also not automatic proof of structural regeneration. A more accurate description is an autologous biological procedure with potential reparative or regenerative effects.
What should be documented in clinical practice?
Meaningful documentation should state more than “PRP injection”. It should include the system used, collected blood volume, anticoagulant, rotor and centrifugation parameters, final volume, known cellular composition, application site and delivered amount.
1Blood collectionsterile intended system
2Centrifugationmatch RCF, rotor and time
3Fraction selectioncollect a defined plasma fraction
4Applicationindication-specific and aseptic
The instructions for use of the tube and centrifuge, the facility’s SOP, hygiene requirements and applicable law remain authoritative. RPM values should not be transferred between devices without checking because actual RCF depends on rotor radius.
A balanced assessment of PRP
PRP has biologically plausible properties and is being studied across many specialties. Some indications show evidence of clinical benefit. At the same time, composition, dose and use are not standardised enough to justify describing PRP as a universal standard therapy.
A sound assessment must ask: Which condition is being treated? What PRP product is actually prepared? Which outcomes are supported? What alternatives and risks exist? Suitability and performance should be determined by appropriately qualified healthcare professionals.
Notice: This article provides professional information and does not replace individual diagnosis, consent or treatment decisions.
Further reading
Technical background, products and calculation tools for professional PRP workflows.
PRP material →Tubes, sets, accessories and professional practice supplies.Centrifuges →Equipment for professional sample and PRP preparation.RCF/RPM calculator →Convert centrifugal force and speed using the actual rotor radius.PRP centrifugation →Understand RCF, RPM, rotor, runtime and protocols.Vi PRP-PRO data →Product data and technical centrifugation context.
Sources and guidance
Selected sources for professional context. Evidence must always be interpreted for the specific indication.
- AAOS – Platelet-Rich Plasma for Knee Osteoarthritis: Technology Overview
- NICE – Platelet-rich plasma injections for knee osteoarthritis
- NICE – Autologous blood injection for tendinopathy
- PubMed – Adverse events related to platelet-rich plasma therapy
- PubMed – Effect of platelet dose on outcomes after PRP injections
- PubMed – Systematic review of PRP in medical and surgical specialties